Ronaldo Lúcio Rangel Costa

Author

Instituto Brasileiro de Controle do Câncer ORCID

Also Known As

R Costa, R L R Costa, R Lucio Rangel Costa, R. Costa, R. L. R. Costa, R. L.R. Costa, R.L.R. Costa, R.R. Costa, RANGEL, RONALDO LÚCIO COSTA, RONALDO LÚCIO COSTA RANGEL

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Instituto Brasileiro de Controle do Câncer Ludwig Cancer Research AC Camargo Hospital Universidade Estadual de Campinas (UNICAMP)Karolinska Institutet

About

Ronaldo Lúcio Rangel Costa is an author at Instituto Brasileiro de Controle do Câncer specializing in medicine, oncology, and cervical cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	2.6K
2	Immunology	2	2	919
3	Engineering	1	1	80
4	Public Health	1	1	18
5	Cell Biology	1	1	30

Ronaldo Lúcio Rangel Costa

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta, The Lancet Oncology VaccinationVaccinologyVaccine DevelopmentCervical CancerHuman Papillomavirus Vaccines	2005	1.6K
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta, British Journal of Cancer	2006	804
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18 Luisa L. Villa, Kevin A. Ault, Anna R. Giuliano, Vaccine VaccinationVaccine DevelopmentHuman Papillomavirus VaccinesVaccine TargetImmunology	2006	465
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine Sven‐Eric Olsson, Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Vaccine VaccinationVaccine DevelopmentL1 Virus-like ParticleHuman Papillomavirus VaccinesImmune Memory	2007	454
The use of 99mTc-phytate for sentinel node mapping in melanoma, breast cancer and vulvar cancer: a study of 100 cases Maria Tavares, Marcelo Tatit Sapienza, Nassif A. Galeb, European Journal of Nuclear Medicine and Molecular Imaging Breast OncologyEngineeringMedicineMelanomaTheranostics	2001	80
Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial) Glauco Baiocchi, Carlos Eduardo Mattos Cunha Andrade, Reitan Ribeiro, International Journal of Gynecological Cancer	2022	47
Cox-2, EGFR, and ERBB-2 Expression in Cervical Intraepithelial Neoplasia and Cervical Cancer Using an Automated Imaging System Elza Mieko Fukazawa, Glauco Baiocchi, Fernando Augusto Soares, International Journal of Gynecological Pathology Cox-2 Mean ExpressionOncologic ImagingPathologyCancer BiologyTumor Biology	2014	30
A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma Òren Smaletz, Maria Del Pilar Estevez-Diz, Claudio Calazan do Carmo, Gynecologic Oncology Gastrointestinal OncologyMedicinePlatinum Resistant/refractoryGynecologyFallopian Tube	2015	24
Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study André Lopes, Ronaldo Lúcio Rangel Costa, Raphael di Paula, International Journal of Gynecological Cancer	2019	22
Open Versus Minimally Invasive Radical Hysterectomy in Cervical Cancer: The CIRCOL Group Study Glauco Baiocchi, Reitan Ribeiro, Ricardo dos Reis, Annals of Surgical Oncology Gynecologic SurgeryCervical Cancer ManagementSurgical OncologyCervical CancerCervical Health	2021	18

Page 1